Kyle Kimura, MD
Otolaryngology · Merriam, KSNPI 1013361005
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $927 of the $1,357 with a category attached, or 68.3%. 13 manufacturers reported payments, led by Medical Device Business Services, Inc. at 31.7% of the total. Reporting peaked in 2023 at $822 and has fallen 77.3% since, to $187 in 2025.
Across 25 payments — averaging $54.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$430
- Musculoskeletal Transplant Foundation Inc.$217
- Kerecis Limited$145
- Sanofi$144
- Stryker$125
- Optinose US, Inc.$72
- plus $225 from 7 others
What the payments were for
- Travel & lodging$43032%
- Food & beverage$92768%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 2 | $430 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $217 |
| Kerecis Limited | 1 | $145 |
| Sanofi | 6 | $144 |
| Stryker | 2 | $125 |
| Optinose US, Inc. | 3 | $72 |
| Kls-martin L.p. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Innovation Technologies Inc | 1 | $37 |
| Hologic Sales And Service, LLC | 1 | $32 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| Vertex | 1 | $24 |
| GSK | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,357 in reported general payments places this provider in the 55th percentile of 87 otolaryngology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 28 | $1,526 |
| Famotidine | 58 | $947 |
| Insulin SyringeSyringe And Needle,insulin,1ml | 13 | $497 |
| Cephalexin | 27 | $464 |
| Omeprazole | 29 | $458 |
| Azelastine Hcl | 14 | $402 |
| Ofloxacin | 13 | $397 |
| Fluticasone Propionate | 17 | $227 |
| Doxycycline Monohydrate | 11 | $211 |
| Oxycodone Hcl | 33 | $149 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $126 |
| Prednisone | 29 | $99 |
| Montelukast Sodium | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Merriam
- Stanley McClurgMerriam$133K
- Nicholas WirtzMerriam$14K
- Katherine AberleMerriam$4K
- Jason ShowmakerMerriam$2K
- Hinrich StaeckerKansas City$499K
- Douglas CowanLeawood$32K
- Jennifer VillwockKansas City$26K
- David RudmanOverland Park$18K
- Meha FoxKansas City$12K
- Kiran KakaralaKansas City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.